<i>PLEKHA8P1</i> Promotes Tumor Progression and Indicates Poor Prognosis of Liver Cancer
Hepatocellular carcinoma (HCC) records the second-lowest 5-year survival rate despite the avalanche of research into diagnosis and therapy. One of the major obstacles in treatment is chemoresistance to drugs such as 5-fluorouracil (5-FU), making identification and elucidation of chemoresistance regu...
Main Authors: | Jiyeon Lee, Ji-Hyun Hwang, Harim Chun, Wonjin Woo, Sekyung Oh, Jungmin Choi, Lark Kyun Kim |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/14/7614 |
Similar Items
-
WW, PH and C-Terminal Domains Cooperate to Direct the Subcellular Localizations of PLEKHA5, PLEKHA6 and PLEKHA7
by: Sophie Sluysmans, et al.
Published: (2021-09-01) -
PLEKHA4 is Associated with Tumour Microenvironment, Stemness, Proliferation and Poor Prognosis of Gliomas
by: Xin Gao, et al.
Published: (2023-08-01) -
PLEKHA4 is a novel prognostic biomarker that reshapes the tumor microenvironment in lower-grade glioma
by: Wenqian Zhi, et al.
Published: (2023-09-01) -
Bioengineered PLEKHA7 nanodelivery regularly induces behavior alteration and growth retardation of acute myeloid leukemia
by: Sameh A. Mohammed, et al.
Published: (2022-06-01) -
Salinity stress alters the expression patterns of novel miR‐2008 and its target gene PLEKHA3 in the sea cucumber Apostichopus japonicus
by: Yi Tian, et al.
Published: (2023-08-01)